Home » Topics » Regulatory » Patents

Patents
RSS

MDC, Forschungsverbund Berlin disclose THP2 inhibitors

Sep. 7, 2016

Reata Pharmaceuticals presents nitric oxide production inhibitors

Sep. 7, 2016

NeuPharma patents BTK/EGFR inhibitors

Sep. 7, 2016

Bristol-Myers Squibb divulges nonstructural protein 5B inhibitors

Sep. 7, 2016

SciFluor Life Sciences presents integrin beta-6/8 antagonists

Sep. 7, 2016

University of Southern California team reveals growth hormone receptor antagonists

Sep. 6, 2016

Agents for RSV infections described in Aviragen Therapeutics patent

Sep. 6, 2016

Lilly prepares and tests MetAP 2 and DPP IV inhibitors

Sep. 6, 2016

NEONC Technologies patent reports agents for treatment of cancer

Sep. 6, 2016

Latvian Institute of Organic Synthesis patents LeuRS inhibitors

Sep. 6, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...